Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Sana Biotechnology, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 178 | 2 | 203 | +27 |
| Shares | 163.7M | 14.4K | 159.2M | −4.42M (−2.7%) |
| Value | $581.8M | $51.2K | $648.8M | +$67.0M (+11.5%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (48)
Institutions that held Sana Biotechnology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (21)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Clearline Capital LP | 524,547 | $1.86M |
| LMR Partners LLP | 242,553 | $861.1K |
| Ovata Capital Management Ltd | 100,000 | $355.0K |
| Walleye Capital LLC | 77,080 | $273.6K |
| Quadrature Capital Ltd | 61,232 | $217.4K |
| Jacobs Levy Equity Management, Inc | 60,475 | $214.7K |
| Graham Capital Management, L.P. | 44,570 | $158.2K |
| Employees Retirement System of Texas | 34,669 | $123.0K |
| Two Sigma Securities, LLC | 33,294 | $118.2K |
| Jain Global LLC | 32,227 | $114.4K |
| Jupiter Asset Management Ltd | 26,416 | $93.8K |
| Larson Financial Group LLC | 20,000 | $71.0K |
| Vident Advisory, LLC | 19,645 | $69.7K |
| Prudential Financial Inc | 16,860 | $59.9K |
| CIBC World Markets Inc. | 14,000 | $49.7K |
| WJ Financial Advisors LLC | 12,000 | $42.6K |
| Smith, Moore & Co. | 11,250 | $39.9K |
| D.A. Davidson & Co. | 11,220 | $39.8K |
| Wealthspire Advisors, LLC | 1,030 | $3.66K |
| Groupe la Francaise | 1,000 | $3.01K |
| Sofos Investments, Inc. | 100 | $355 |
Not filed for Q4 2025 yet (2)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| CIBC Bancorp USA Inc. | 14,222 | $50.5K |
| Pineridge Advisors LLC | 200 | $710 |